December 22, 2021
411
9
10
4.62%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:29Now PlayingPfizer Inc.’s Covid-19 pill gained clearance for emergency use in the U.S., delivering a more convenient treatment option for at-risk patients at a critical point in the pandemic.
The drug, called Paxlovid, is the first at-home therapy for Covid-19 to win clearance from the Food and Drug Administration. It is expected to become a potent weapon in battling the virus once production gears up, giving people at high risk of severe complications from the disease a way to avoid winding up in the hospital.
“This authorization provides a new tool to combat Covid-19 at a crucial time in the pandemic as new variants emerge,” said Patrizia Cavazzoni, director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, in a statement on Wednesday.
Subscribe to our YouTube channel
Subscribe to our newest channel Quicktake Explained
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.